Balázs Győrffy MD PhD DSc MAE
Balázs Győrffy MD PhD DSc MAE
Full Professor, Semmelweis University, Hungarian Academy of Sciences, member of Academia Europaea
Verified email at
Cited by
Cited by
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
B Györffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi
Breast cancer research and treatment 123 (3), 725-731, 2010
Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer
B Győrffy, P Surowiak, J Budczies, A Lánczky
PloS one 8 (12), 2013
Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization
J Budczies, F Klauschen, BV Sinn, B Győrffy, WD Schmitt, ...
PloS one 7 (12), 2012
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
AM Szász, A Lánczky, Á Nagy, S Förster, K Hark, JE Green, ...
Oncotarget 7 (31), 49322, 2016
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
B Győrffy, A Lánczky, Z Szállási
Endocrine-related cancer 19 (2), 197-208, 2012
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
A Lánczky, Á Nagy, G Bottai, G Munkácsy, A Szabó, L Santarpia, B Győrffy
Breast cancer research and treatment 160 (3), 439-446, 2016
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Á Nagy, A Lánczky, O Menyhárt, B Győrffy
Scientific reports 8 (1), 1-9, 2018
Jetset: selecting the optimal microarray probe set to represent a gene
Q Li, NJ Birkbak, B Gyorffy, Z Szallasi, AC Eklund
BMC bioinformatics 12 (1), 474, 2011
Multigene prognostic tests in breast cancer: past, present, future
B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai
Breast cancer research 17 (1), 11, 2015
Multigene prognostic tests in breast cancer: past, present, future
B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai
Breast cancer research 17 (1), 11, 2015
Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations
B Györffy, P Surowiak, O Kiesslich, C Denkert, R Schäfer, M Dietel, ...
International journal of cancer 118 (7), 1699-1712, 2006
Systematic evaluation of the miRNA‐ome and its downstream effects on mRNA expression identifies gastric cancer progression
O Tchernitsa, A Kasajima, R Schäfer, RJ Kuban, U Ungethüm, B Györffy, ...
The Journal of pathology 222 (3), 310-319, 2010
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
Z Mihály, M Kormos, A Lánczky, M Dank, J Budczies, MA Szász, B Győrffy
Breast cancer research and treatment 140 (2), 219-232, 2013
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
DC Porter, E Farmaki, S Altilia, GP Schools, DK West, M Chen, BD Chang, ...
Proceedings of the National Academy of Sciences 109 (34), 13799-13804, 2012
The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1
R Abdul-Ghani, V Serra, B Györffy, K Jürchott, A Solf, M Dietel, R Schäfer
Oncogene 25 (12), 1743-1752, 2006
Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus
B Györffy, B Vásárhelyi, D Krikovszky, L Madácsy, A Tordai, T Tulassay, ...
European journal of endocrinology 147 (6), 803-808, 2002
Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
L Magnani, A Stoeck, X Zhang, A Lánczky, AC Mirabella, TL Wang, ...
Proceedings of the National Academy of Sciences 110 (16), E1490-E1499, 2013
Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue–a GC-TOFMS based metabolomics study
J Budczies, C Denkert, BM Müller, SF Brockmöller, F Klauschen, B Györffy, ...
BMC genomics 13 (1), 334, 2012
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
H Zhang, SK Ramakrishnan, D Triner, B Centofanti, D Maitra, B Győrffy, ...
Sci. Signal. 8 (397), ra98-ra98, 2015
Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples
B Gyorffy, B Molnar, H Lage, Z Szallasi, AC Eklund
PloS one 4 (5), 2009
The system can't perform the operation now. Try again later.
Articles 1–20